Tongue Cancer Clinical Trials

54 clinical trials for Tongue Cancer across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Normative Ranges of Lingual Strength and Endurance and the Impact of the IOPI Lingual Strength Trainer on Quantitative Functional Outcomes and Patient-Reported Outcomes After Partial Glossectomy or Hemiglossectomy for Oral Tongue Cancer, An Unblinded: Randomized Pilot Study — RECRUITING · NA
• Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial — RECRUITING · NA
• Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue — RECRUITING · NA
• Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck — RECRUITING · NA
• Arabic PRO Measures for Head and Neck Cancer Radiotherapy. — RECRUITING
• Anterolateral Thigh Myofascial Fat Composite Flap for Reconstruction of Hemiglossectomy Defects in Obese Patients With Tongue Cancer — ACTIVE_NOT_RECRUITING
• Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab — COMPLETED · PHASE2
• Clinical Study Evaluating the Proper Surgical Safety Margin for Early Stage Oral Tongue Cancers — TERMINATED · NA
• Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer — COMPLETED
• The Registry of Oncology Outcomes Associated With Testing and Treatment — COMPLETED
• Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer — SUSPENDED · PHASE1
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer — COMPLETED · PHASE1
• Radiotherapy of Tongue Cancer Using an Intraoral Stent — COMPLETED · PHASE1
• Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene — COMPLETED · PHASE1
• Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy — WITHDRAWN · PHASE1
• Surgical Margin Assessment by 3D Ultrasound — OTHER · NA
• Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S — COMPLETED · PHASE1
• Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity — WITHDRAWN · NA
• Ultrasound in Tongue Cancer- a Help to Decide Depth of Invasion and to Improve the Surgical Margin — COMPLETED · NA
• PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer — COMPLETED · PHASE1
• GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer — COMPLETED · PHASE3
• Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer — TERMINATED · NA
• Oral Stent Device for Radiation Treatments of Oral Cancers — WITHDRAWN
• Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer Survivors — COMPLETED · NA
• Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. — COMPLETED · PHASE1
• Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care — COMPLETED · NA
• Quality of Life in Patients Treated for Tongue and/or Jaw Neoplasia Before and After Speech Therapy — COMPLETED · NA
• 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy — COMPLETED · PHASE1
• High-activity Natural Killer Immunotherapy for Small Metastases of Tongue Cancer — COMPLETED · PHASE1
• Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy — COMPLETED · PHASE2
• Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck — COMPLETED · PHASE1
• Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer — COMPLETED · PHASE2
• A Study of Tongue Conservation Surgery for Oral Tongue Cancer — TERMINATED · PHASE2
• Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer — TERMINATED · PHASE1
• Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer — COMPLETED · PHASE1
• Patient Preferences in Making Treatment Decisions in Patients With Stage I-IVA Oropharyngeal Cancer — TERMINATED
• Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer — COMPLETED · PHASE2
• Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer — WITHDRAWN · PHASE2
• TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck — COMPLETED · PHASE1
• Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia — COMPLETED · PHASE2
• Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer — COMPLETED · PHASE2
• Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer — WITHDRAWN · NA
• Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer — COMPLETED · PHASE1
• Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck — COMPLETED · PHASE2
• Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer — COMPLETED · PHASE2
• Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy — WITHDRAWN · PHASE1
• Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck — TERMINATED · PHASE1
• Effects of Different General Anesthesia Methods on Immune Responses in Patients Undergoing Surgery for Tongue Cancer — OTHER · NA
• Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy — WITHDRAWN · PHASE2
• S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer — COMPLETED · PHASE2

Refine this search